Real-time enrollment status for this early alzheimer's disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:09 AM UTC
| NCT Number | NCT06874621 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Early Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 52 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Voyager Therapeutics |
| Last Updated on CT.gov | November 19, 2025 (Nov 19, 2025) |
As of March 2, 2026: Clinical trial NCT06874621 is currently active_not_recruiting participants. This clinical trial study for early alzheimer's disease is not currently accepting new participants at 19 locations across the United States. The study is sponsored by Voyager Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06874621 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06874621 was last updated Nov 19, 2025 (November 19, 2025). HelloStudys verifies this status automatically.